Telehealth Capacity Assessment Tool (TCAT)
Guides behavioral health organizations through assessing readiness to adopt telehealth
This collection of tools and resources is for providers, staff, and patients who offer or use services to address substance use, and other interested stakeholders. This collection was originally established following an environmental scan on implementing medication-assisted treatment (MAT) for opioid use disorder (OUD) in rural primary care. (See PDFs of Volume 1 [PDF 0.69 MB] and Volume 2 [PDF 1.28 MB] of that scan). Items have been continuously added to this collection since then, and the collection has expanded to cover substance use more broadly, rather than just MAT for OUD.
Guides behavioral health organizations through assessing readiness to adopt telehealth
This fact sheet discusses the benefits of early screening, brief intervention, and referrral to treatment, including saving lives and reducing health care costs.
Provides clinical recommendations for initiating and maintaining chronic opioid therapy of 90 days or longer.
Assesses the evidence regarding the use and abuse of opioids by chronic noncancer pain patients to create a set of clinical practice guidelines for the responsible prescribing of opioids.
Provides information on the potential benefits and risks of opioid medications and documents that both the patient and provider agree on a care plan.
Offers clinicians information on medications for opioid addiction treatment, including side effects, drug interactions, and take-home doses. Discusses patient counseling, associated medical problems, hepatitis C evaluation, drug testing, and pregnant women.
Describes the nature and dimensions of OUDs and their treatment, consensus panel recommendations and evidence-based best practices for opioid treatment programs (OTPs), related co-occurring disorders and their treatment, and ethical considerations that arise in most OTPs.